seed
Stage
1
Investors
About
Imagenomix develops rapid, low-cost, and highly scalable mutation detection technology that uses artificial intelligence to identify genetic variants. The company focuses on AI-enabled diagnostics for mutation detection workflows.
Explore Imagenomix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.